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Owing to an error by the authors, an inappropriate
publication was cited as reference 71. The correct reference
is:
71. Verdrengh M, Bokarewa M, Ohlsson C, Stolina M,
Tarkowski A (2010) RANKL-targeted therapy inhibits bone
resorption in experimental Staphylococcus aureus-induced
arthritis. Bone 46(3):752–758
The online version of the original article can be found at http://dx.doi.
org/10.1007/s00198-010-1326-y.
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